Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Būtiski notikumi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-05-02 10:30:27 |
Versijas komentārs | |
Teksts |
Olaine,May 2, 2013
OlainFarm
has Acquired 47.5% of Shares in Silvanols
AS “OlainFarm” has acquired 47.5% shares in the third largest
Latvian pharmaceutical manufacturer SIA “Silvanols”. It is
expected that another 20% or more will be acquired in the nearest
future. This acquisition will allow both companies to expand their
product groups and portfolio and enter and expand into new
markets.
“Over last several years OlainFarm has made significant
investments in expansion of its product portfolio, sales markets
and business segments. Acquisition of Silvanols is yet
another step towards vision of OlainFarm to become a leading
producer of finished dosage forms and chemical products in the
Baltics, whose products is well known and available throughout the
world. We see a very good opportunity to increase the speed
of growth by merging expertise, experience and export potential of
the two companies and by creating and developing joint
projects,”
says Salvis Lapins, Member of the Board of AS
“OlainFarm”.
Co-owner and the Board Member of SIA “Silvanols” Ieva Leimane notes
that “this is a logical next step in company’s development.
Having a new shareholder in Silvanols will help the company
to develop faster, improve its logistical systems, and, what is
particularly important, will provide new export markets for the
company. I am sure and our recent experience confirms it, that our
products are veru compatitive not only in Latvia but also
abroad.”
Chairman of the
Board of SIA “Silvanols” Viesturs Gurtlavs emphasizes that “changes
that have occurred to list of company’s shareholders will
facilitate inflow of new knowledge and experience into Silvanols
which will be yet another boost for competitiveness of the company
internationally and domestically”.
After the
transaction Board Member of Olainfarm Mr. Salvis Lapins has also
become a Member of Silvanols’ Board.
Sales of SIA
„Silvanols” in 2012 were 1.993 million lats and the company made a
net profit of 136 thousand lats.
Consolidated
profit and loss statement of AS "OlainFarm" for 2012 shows that the
concern has set yet another profit record as it has made a net
profit of 9.75 million lats (13.88 milion euro). This
represents an increase by 41% compared to 2011, when profit of
AS "OlainFarm" was 6.91 million lats (9.84 million
euro).
A/s
OlainFarm is one of the biggest pharmaceutical companies in Latvia
with 40 years of experience in production of medication and
chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 30 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia.
SIA "Silvanols" is one of the most rapidly growing Latvian
producers of medicines. In its operations
SIA "Silvanols" uses modern
internationally applied technologies. Products portfolio of the
company consists of unique set of original products, including
over-the-counter medicines, medical devices and food supplements,
in total more than 70 different original products. Company is
particularly proud of their original products, including market
leader Faringo Spray®, anti-rhinitis gel Rinogēls® and sedative
mixture of 7 different herbs Relaxen®. Currently products of
the company are being exported to Lithuania, Estonia, Azerbaijan,
Romania, Czech Republic, Hungary, Belarus, Kazakhstan, Slovakia and
Armenia.
Information prepared by:
Salvis
Lapins
JSC
“Olainfarm”
Member of the
Management Board
Rupnicu iela 5,
Olaine
Latvia, LV
2114
Phone: +371 6 7013
717
Fax: +371 6 7013
777
e-mail:
slapinsh@olainfarm.lv
|
Pielikumi |
|